SS Innovations International, Inc. Stock

Equities

SSII

US05453U2033

Biotechnology & Medical Research

Market Closed - OTC Markets 12:56:52 2024-04-25 pm EDT 5-day change 1st Jan Change
4.99 USD +0.20% Intraday chart for SS Innovations International, Inc. -9.27% -31.17%
Sales 2022 1.46M Sales 2023 5.88M Capitalization 1.24B
Net income 2022 -3M Net income 2023 -20M EV / Sales 2022 * -
Net Debt 2022 6.03M Net Debt 2023 6.2M EV / Sales 2023 212 x
P/E ratio 2022 *
-
P/E ratio 2023
-44.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 19.55%
More Fundamentals * Assessed data
Dynamic Chart
SS Innovations International, Inc.?s SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures CI
SS Innovations International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
SS Innovations? SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement CI
SS Innovations International, Inc. announced that it has received $1 million in funding from Sushruta Pvt. Ltd CI
Ss Innovations International, Inc. Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health of the United States Food and Drug Administration CI
SS Innovations International, Inc. Announces Strategic Partnership with Surgical Lab for Distribution in Africa CI
SS Innovations International, Inc. Announces Successful Completion of 500 Robotic Surgery Using the Company's Innovative SSi Mantra Surgical Robotic System CI
SS Innovations International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
SS Innovations International, Inc. Appoints Sonia Shokeen as Head of Quality and Regulatory Affairs CI
SS Innovations Enters Licensing Agreement with Johns Hopkins University CI
SS Innovations International, Inc. Appoints Colin Eke to Lead Global Business Development CI
SS Innovations International, Inc. Launches Innovative Robotic Cardiac Surgery Program in India CI
SS Innovations International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
SS Innovations International, Inc. Announces Board Appointments CI
Government Institution Adopts SS Innovations International, Inc.'s SSi Mantra Surgical Robotic System CI
More news
1 day+0.20%
1 week-9.27%
Current month-16.83%
1 month-16.83%
3 months+8.48%
6 months-50.05%
Current year-31.17%
More quotes
1 week
4.25
Extreme 4.25
5.55
1 month
4.25
Extreme 4.25
6.25
Current year
3.00
Extreme 3
8.50
1 year
3.00
Extreme 3
18.00
3 years
3.00
Extreme 3
18.00
5 years
3.00
Extreme 3
18.00
10 years
3.00
Extreme 3
18.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 76 23-04-13
Founder 84 15-02-03
President 47 23-04-13
Members of the board TitleAgeSince
Founder 84 15-02-03
Chief Executive Officer 76 23-04-13
President 47 23-04-13
More insiders
Date Price Change Volume
24-04-25 4.99 +0.20% 304
24-04-24 4.98 -10.27% 696
24-04-22 5.55 +0.91% 2,711
24-04-19 5.5 -7.56% 1,563

Delayed Quote OTC Markets, April 25, 2024 at 12:56 pm EDT

More quotes
SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company is developing a fully autonomous medical robotic system using software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). Its product range includes its SSI Mantra surgical robotic system, and SSI Mudra is its range of surgical instruments capable of supporting a variety of surgical procedures, including robotic cardiac surgery. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset. The SSi Mantra is comprised of vision cart, which provides an additional 32-inch 3D 4K resolution monitor, identical to the surgeon’s console, for the operating room staff.
More about the company